Hypoglycemia aggravates cognitive degeneration by activating endothelial ZBP1-mediated PANoptosis in type 2 diabetic mice.

Authors

Wenping Luo, Qian Xiao, Na Li

Published in

Frontiers in pharmacology. Volume 17. Pages 1825677. Epub Jul 01, 2026.

Abstract

Recurrent hypoglycemia increases cognitive impairment in diabetic patients. Following cerebral neuron injury, endothelial cells provide morphological, metabolic, and immune support to damaged neurons, but the inflammatory mechanism underlying hippocampal neuron degeneration remains unclear.
The Morris water maze test was performed to measure cognitive changes in type 2 diabetic mice. ZBP1 expression was knocked down via small interfering RNA transfection in bEnd.3 brain endothelial cells.
PANoptosis, a defined form of programmed cell death (PCD), was increased by hypoglycemia in the hippocampus of diabetic mice in vivo and by low glucose in bEnd.3 cells in vitro. ZBP1 knockdown reduced low-glucose-induced PANoptosis in high-glucose-cultivated bEnd.3 cells. RNA transcriptomics sequencing revealed that AGE-RAGE signaling was significantly altered after ZBP1 knockdown, which was confirmed by biochemical data.
Hypoglycemia impairs cognition in diabetic mice by activating brain endothelial ZBP1-mediated PANoptosis via the AGE-RAGE axis. Targeting ZBP1 may represent a novel therapeutic strategy for diabetes-associated cognitive dysfunction.

PMID:
42460020
Bibliographic data and abstract were imported from PubMed on 16 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.